Immunogenicity and Safety of Butantan Quadrivalent Influenza Vaccine (Split Virion, Inactivated) in Infants and Children .

Clinical trial NCT05779020 · COMPLETED

Trial details

NCT number: NCT05779020
Sponsor: Butantan Institute
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2023-04-25
Primary completion: 2024-09-12
Enrollment: 1373

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.